The US healthcare system is going through advanced challenges to affordability and entry. In this episode of the McKinsey on Healthcare podcast, McKinsey Senior Partner Celia Huber is joined by Brian Evanko, president and COO of The Cigna Group. As COO, Evanko oversees the entire firm’s companies inside its two development platforms: Cigna Healthcare (for well being advantages) and Evernorth (for well being companies).
In his 27 years with the corporate, Evanko has seen important change within the healthcare panorama, together with development in focused drugs for uncommon ailments, the introduction of the Affordable Care Act, the COVID-19 pandemic, and the rise of GLP-1s. Through each main shift, rising prices have remained a problem, particularly in chronic-disease administration. Below, Evanko shares his perspective on the innovation wanted, together with the adoption of AI, to drive sustainable change in healthcare.
A condensed model of the dialog follows.
The evolution of the healthcare trade
Celia Huber: How has the healthcare trade developed throughout your profession at The Cigna Group?
Brian Evanko: The trade has modified tremendously over the 27 years that I’ve been at The Cigna Group. When you step again and take into consideration the advantages to society, there’s been an amazing quantity of innovation throughout healthcare, from units to prescribed drugs. For instance, robots can now conduct surgical procedures with help from docs, there are cures for ailments that we didn’t assume had been potential prior to now, and, extra lately, GLP-1s are having a useful impression on society.
The converse of all that’s affordability. Affordability is drawback primary within the US healthcare system. Back in 2000, healthcare was about 13 % of US GDP. Now, it’s about 18 %. High-cost prescribed drugs are a serious a part of the issue: While solely 10 % of all prescribed drugs within the United States are brand-name medicines, they characterize a startling 88 % of the spending.
Celia Huber: As you look ahead, what main modifications do you anticipate within the healthcare area?
Brian Evanko: Many features are ripe for change. One is prescription drug innovation—utilizing biosimilars, generics, and the facility of competitors to drive prices down.
Second, shoppers have rising expectations for his or her experiences throughout all industries. And the healthcare trade has a protracted technique to go in that regard. We see a future the place know-how, superior analytics, and AI will result in a extra personalized healthcare expertise for people.
It all begins with understanding people and subsegments of populations to ensure our options are applicable not for averages, however for a person’s wants. And an enormous a part of that’s ensuring folks have the precise data on the proper time. We see folks making decisions that aren’t financially optimum or opting into pointless care. For instance, if somebody wants a knee substitute, that’s an elective process; they’re in a position to take their time deciding when and the place that process transpires, what physician performs it, and what the follow-up routine is. We have a possibility to supply the affected person with all the data they should make these selections. We’re particularly enthusiastic about our new mannequin for pharmacy advantages, which is able to decrease prices for shoppers straight on the pharmacy counter and apply to their deductible. It brings collectively the understanding of the wants of shoppers with innovation to decrease prices and create a extra seamless shopper expertise.
Improving affected person care journeys
Celia Huber: What alternatives do you see for bettering the care journey in your members by partnership and collaboration in addition to website of care?
Brian Evanko: Partnership is a trademark of our firm technique. We don’t personal doctor teams, hospitals, or surgical facilities as a result of we imagine that being a associate to suppliers results in higher outcomes. Providers don’t really feel like we’re competing with them, and we are able to provide them with all of the scientific knowledge and data for sufferers to help one of the best outcomes for each particular person.
Similarly, in our Evernorth enterprise, we associate very carefully with well being methods and hospitals to assist them run their in-house pharmacies—akin to supporting stock administration or coordinating care throughout completely different settings—as a result of the affected person is simply of their hospital or well being system quickly.
In phrases of websites of care, telehealth turned extra frequent within the pandemic, nevertheless it wasn’t a brief phenomenon. The degree of care by our digital platform, MD Live, is far greater now than it was pre-pandemic on a sustained foundation. And we discovered that folks prefer to work together nearly with their docs in a number of instances. For mother and father, serving to their youngster get care shortly in their very own dwelling for much less advanced situations, such because the flu or pink eye, is a game-changer.
Last, by our specialty pharmacy enterprise, now we have about 600 dwelling infusion nurses who journey to the houses of people that require advanced, clinically intensive specialty drugs, akin to people with most cancers. This is crucial for sufferers in order that they don’t must journey to an infusion middle or hospital to obtain care.
Celia Huber: How do you see the position of the well being insurer evolving, and are there pressing challenges that well being insurers want to handle?
Brian Evanko: Over the previous 12 months, there’s been an increase in public scrutiny round belief with well being insurers. We don’t resist this reality, and we spent a number of time listening to know the explanations behind that mistrust and taking motion.
We see two actual alternatives within the face of those challenges. One is to focus on being an advocate to these we serve by our medical insurance enterprise: serving to people and employers navigate the complexity.
The different is to work towards a system that works for everyone, and never only for most individuals. Imagine if the particular person in want of care and help is your buddy or a member of the family. While most individuals are happy with their well being advantages, instances which can be essentially the most sophisticated are sometimes those we have to put further sources behind.
To do this stuff, insurers must get higher at listening to ensure we actually perceive what our sufferers are feeling. It goes past name facilities. Insurers ought to be listening to social media and focus teams in addition to supplier companions to listen to what they’re experiencing, too.
Pursuing innovation and harnessing know-how
Celia Huber: How are you eager about innovation throughout the group? What investments are you making?
Brian Evanko: Innovation requires intentionality. The general area is ripe for innovation by know-how—to enhance care journeys and affected person experiences. At Cigna Healthcare, we’ve been targeted on our cellular app and making it as intuitive as potential. This has included introducing an AI-powered digital assistant, which permits folks to get solutions to lots of their questions in actual time with out having to make a telephone name.
At Evernorth, we’ve launched quite a lot of applications over the previous 18 months which can be targeted on offering entry to GLP-1s at an inexpensive value and in a method that ensures affected person security. For instance, now we have a program that caps affected person out-of-pocket prices at $200 per thirty days for these very costly medication.
Finally, in our specialty pharmacy, we’ve been targeted on AI use instances for unstructured knowledge. When a prescription is written for a high-cost, clinically intensive specialty treatment, we want to ensure it’s applicable earlier than it’s really distributed. With AI, we’ve been in a position to course of this knowledge extra shortly, decreasing the period of time between when the prescription is written to once we can ship it out from a number of days to inside a single day.
Celia Huber: How are you deciding what applied sciences to discover? Are there transformative applied sciences you’re most enthusiastic about for his or her potential impression on insurance coverage operations and experiences for members?
Brian Evanko: Certainly, superior analytics and AI might probably deliver breakthroughs. We take a look at potential functions of transformative applied sciences by the lens of “Is it foundational, is it strategic, or is it disruptive?” And then we ask questions like, “Is it in support of stakeholder experience improvements or lowering costs?” Specifically, a lot of our investments thus far have gone towards decreasing foundational working bills.
In the long run, we goal to make extra strategic and disruptive investments targeted on stakeholder expertise enhancements by superior analytics and AI. Ultimately, we count on the US system to be rather more targeted on upstream preventive care—the place diagnostics are used for early detection and sufferers really feel extra empowered to take management of their very own healthcare. For instance, AI-supported full-body scanners might be able to detect cancers ahead of conventional medical know-how has been in a position to do.
Today, 90 % of spending within the US healthcare system is for continual care. That’s what I name a “sick care” system. We must harness know-how and AI upstream to form a simpler, extra sustainable system.
Of course, you must be considerate about AI when medical knowledge is concerned. It’s not about assembly regulatory necessities however making certain that predictive fashions are equitable and that we all the time have a human concerned in care selections. We will proceed to maneuver methodically in making use of these capabilities to scientific functions to make sure there’s no bias and to guard the belief of the sufferers we serve.
Cultivating the subsequent technology of leaders
Celia Huber: What values have formed your method to management, and the way do you consider cultivating the subsequent technology of leaders?
Brian Evanko: At this second of great change, it’s crucial for leaders to have a studying orientation, to learn feverishly and be a sponge for data. I name it assured humility—understanding you don’t know every part but having the arrogance to make decisive decisions on behalf of the group and all the time being guided by readability of objective.
Relatedly, we should create an surroundings the place everybody can contribute at their highest degree. We’re pleased with our legacy of management growth applications and proceed to put money into these applications. Today, we search for folks for these applications who can apply know-how successfully, who’ve a systems-design mindset. They might be actuaries or knowledge scientists or from finance, however they’re in a position to apply know-how to the most important issues in healthcare. Clinicians are additionally extra vital than ever, as are consultants in communications and authorities affairs within the healthcare area. So our growth efforts focus on these younger leaders, offering them structured applications and, in some instances, on-the-job coaching to make them one of the best of their craft so we are able to proceed to be one of the best in ours.
